Hiroka Yamago Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

7/2019	Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently.
12/2017	Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroka Yamago Research Topics

Disease

9	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 01/2015
2	Liver Diseases (Liver Disease) 01/2020 - 10/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 12/2017
2	Liver Neoplasms (Liver Cancer) 01/2017 - 01/2015
2	Hepatitis B 10/2014 - 01/2013
2	Neoplasms (Cancer) 10/2014 - 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020
1	Hepatitis 01/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2019
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2019
1	Chronic Hepatitis B 01/2019
1	Sarcopenia 12/2017
1	Rupture 03/2015
1	Hypophosphatemia 10/2014
1	Crohn Disease (Crohn's Disease) 01/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013

Drug/Important Bio-Agent (IBA)

2	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 05/2017
2	Lamivudine (Epivir)FDA Link 01/2019 - 10/2014
1	ZincIBA 01/2020
1	A 17 (A-17)IBA 07/2019
1	Antiviral Agents (Antivirals)IBA 02/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	tenofovir alafenamideIBA 01/2019
1	adefovirIBA 01/2019
1	Branched-Chain Amino AcidsIBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	BilirubinIBA 05/2016
1	AlbuminsIBA 05/2016
1	vasectrin II (VS II)IBA 03/2015
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	Transaminases (Aminotransferases)IBA 10/2014
1	adefovir dipivoxil (Hepsera)FDA Link 10/2014
1	Infliximab (Remicade)FDA Link 01/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2012

Therapy/Procedure

2	Therapeutics 03/2015 - 10/2014
1	Aftercare (After-Treatment) 02/2019
1	Radiofrequency Ablation 01/2019
1	Retreatment 01/2015
1	Hepatectomy 10/2014